Needham analyst upgrades SYK to Buy, expects new products & M&A to drive upside in revenue & EPS. Strong backlog & growth potential make shares attractive.
Latest Ratings for SYK...
Stryker (NYSE:SYK), a global leader in medical technologies, announced the successful completion of the first European surgeries using the Infinity Total Ankle System with Adaptis and Everlast...
Latest Ratings for SYK
DateFirmActionFromTo Jan 2022Morgan StanleyMaintainsEqual-Weight Jan 2022BTIGMaintainsBuy Jan 2022SVB LeerinkMaintainsOutperform
View More Analyst Ratings for SYK...
Key Events This Extremely Busy Week: Fed, Treasury Refunding, Jobs, JOLTS, ISM And Tons Of Earnings
As DB's Jim Reid notes, with just two days left in a rollercoaster April for markets...
New York State Teachers Retirement System lowered its stake in shares of Stryker Co. (NYSE:SYK - Free Report) by 1.4% in the 4th quarter, HoldingsChannel reports. The firm owned 331,075 shares of the...
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Shop Apotheke Europe NV (GB:0RJT Research Report), Stryker...
Asset Management One Co. Ltd. trimmed its position in Stryker Co. (NYSE:SYK - Free Report) by 2.3% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 140,174 shares...